Lorenzo A, López Sáez J J, Escobar M, Morán A, Senra A, Millán J
Departamento de Medicina Interna, Hospital Provincial y Clínico, Cádiz.
Rev Clin Esp. 1990 Apr;186(6):270-3.
A group of ten patients suffering cirrhosis who were treated with 100 U/l of calcitonin was studied with the aim of knowing whether in patients with cirrhosis the calcitonin is able to provoke the usual characteristic biologic modifications on the basis of the knowledge of their hormonal high levels accompanied of oesteopenia. Regarding their baseline determinations, no statistically significant modifications have been observed in calcium, phosphorous, alkaline phosphatase or its thermostable and thermolabile fractions, magnesium, uric acid and creatinine plasma concentrations respectively. This absence of a biological response to calcitonin could be due either to a numeric or functional damage of the hormone receptors or a diminished biodisponibility, although there are facts suggesting a lesser hormone biopotenciality in these patients.
对一组接受100 U/l降钙素治疗的十名肝硬化患者进行了研究,目的是基于对他们伴有骨质减少的激素高水平的了解,弄清楚在肝硬化患者中降钙素是否能够引发常见的特征性生物学改变。关于他们的基线测定,分别在钙、磷、碱性磷酸酶及其热稳定和热不稳定组分、镁、尿酸和肌酐血浆浓度方面未观察到统计学上的显著改变。降钙素缺乏生物学反应可能是由于激素受体的数量或功能损伤,或者生物利用度降低,尽管有事实表明这些患者的激素生物活性较低。